CMIC Holdings Co Ltd
TSE:2309

Watchlist Manager
CMIC Holdings Co Ltd Logo
CMIC Holdings Co Ltd
TSE:2309
Watchlist
Price: 999 999.9999 JPY 37 893.92% Market Closed
Market Cap: 47.6B JPY
Have any thoughts about
CMIC Holdings Co Ltd?
Write Note

CMIC Holdings Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CMIC Holdings Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
CMIC Holdings Co Ltd
TSE:2309
Operating Income
ÂĄ5.5B
CAGR 3-Years
30%
CAGR 5-Years
5%
CAGR 10-Years
4%
C
Chiome Bioscience Inc
TSE:4583
Operating Income
-ÂĄ1.2B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Precision System Science Co Ltd
TSE:7707
Operating Income
-ÂĄ956.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Medinet Co Ltd
TSE:2370
Operating Income
-ÂĄ1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
CellSource Co Ltd
TSE:4880
Operating Income
ÂĄ1.2B
CAGR 3-Years
43%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Operating Income
ÂĄ1.3B
CAGR 3-Years
34%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

CMIC Holdings Co Ltd
Glance View

Market Cap
47.6B JPY
Industry
Life Sciences Tools & Services

CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Intrinsic Value
1 134 940.8834 JPY
Undervaluation 12%
Intrinsic Value
Price

See Also

What is CMIC Holdings Co Ltd's Operating Income?
Operating Income
5.5B JPY

Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Operating Income amounts to 5.5B JPY.

What is CMIC Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was -57%. The average annual Operating Income growth rates for CMIC Holdings Co Ltd have been 30% over the past three years , 5% over the past five years , and 4% over the past ten years .

Back to Top